You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 5, 8 MAR 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Oral Anticoagulant Therapy—50 Years Later

Jack E. Ansell, MD

Arch Intern Med. 1993;153(5):586-596.


Abstract

The year 1991 marked the 50th anniversary of the first clinical use of oral anticoagulant therapy as a means of preventing thromboembolic disease. Despite long-term physician familiarity with oral anticoagulants, this mode of therapy still suffers from a relatively high-risk/safety profile. This review briefly highlights important historical and pharmacokinetic points of interest but focuses predominantly on aspects of the day-to-day management of anticoagulant therapy aiming to enhance physician performance in this therapeutic milieu. Emphasis is placed on therapeutic monitoring, understanding the prothrombin time, managing complications, and assessing future innovations for the management of a growing population of patients treated with orally administered anticoagulants.



Author Affiliations

From the Department of Medicine, University of Massachusetts Medical School, Worcester, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pulmonary Embolism: What Have We Learned Since Virchow?: Treatment and Prevention
Dalen
Chest 2002;122:1801-1817.
FULL TEXT  

Toward Safer Warfarin Therapy: Does Precise Daily Dosing Improve International Normalized Ratio Control?
Manning
Mayo Clin Proc. 2002;77:873-875.
 

Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Chiquette et al.
Arch Intern Med 1998;158:1641-1647.
ABSTRACT | FULL TEXT  

Treatment of Proximal Vein Thrombosis With Subcutaneous Low-Molecular-Weight Heparin vs Intravenous Heparin: An Economic Perspective
Hull et al.
Arch Intern Med 1997;157:289-294.
ABSTRACT  

Validity of International Normalized Ratio in Expressing Prothrombin Times in Anticoagulated and Nonanticoagulated Patients
Alshameeri et al.
CLIN APPL THROMB HEMOST 1996;2:25-29.
ABSTRACT  

International Normalized Ratio: The New Standard for Monitoring Oral Anticoagulation
Kirk and McGann
Arch Fam Med 1994;3:71-74.
ABSTRACT  

Oral Anticoagulant Therapy
Anand
Arch Intern Med 1993;153:1933-1933.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.